ACTRN12612001027808
Not yet recruiting
Phase 3
Investigation into the Acute and Chronic Effects of Longvida Curcumin on Cognitive Function, Mood and Biomarkers of Health in a Cognitively Healthy Elderly Population Compared to an Elderly Population with Cognitive Decline
Swinburne University of Technology, Centre for Human Psychopharmacology0 sites60 target enrollmentSeptember 24, 2012
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Cognitive function
- Sponsor
- Swinburne University of Technology, Centre for Human Psychopharmacology
- Enrollment
- 60
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male or female.
- •2\. Aged 65\-80 years.
- •3\. Willing and able to provide written informed consent.
- •4\. Understands and is willing and able to comply with all study procedures.
- •5\. Free from history of stroke, other neurological conditions (e.g. Parkinsons, epilepsy), depression, psychiatric disorders, low base line intellect, alcohol abuse past / present.
- •6\. Cognitively healthy participants must be free from any form of cognitive impairment. For the cognitively declined particpants, participants must have objective memory impairment for age and education level.
- •7\. Free from dementia.
- •8\. English speaking.
- •9\. Must have normal or corrected vision.
- •10\. Free from other medical conditions which may affect ability to participate in the study
Exclusion Criteria
- •1\. Any significant concurrent illness including any auto\-immune disorder, bleeding disorders, heart conditions, diabetes, glaucoma, high blood pressure or osteoporosis.
- •2\. Any known or suspected food allergies
- •3\. Smokers and users of recreational drugs (except alcohol and other food grade actives).
- •4\. Have participated in any other study involving an investigational product in the last 4 weeks.
- •5\. Taking any of the following: anti\-coagulant drugs (Warfarin,Heparin, Plavix); anti\-cholinergics or acetylcholinesterase inhibitors: bethanechol (Ureholine), donepezil (Aricept),
- •6\. Taking steroid medications
- •7\. Taking vitamins or herbal supplements regularly
- •8\. Left\-handed participants will be ineligible to take part in Stage Two
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the acute- and long-term results after endovascular therapy of the popliteal arteryI70.22DRKS00019096niversitäts-Herzzentrum Bad Krozingen378
Completed
Not Applicable
Evaluation of acute and long-term outcomes ofatherectomy in femoropoliteal and infrapopliteal lesionsI70.22DRKS00031245niversitäts-Herzzentrum Campus Bad Krozingen - Uniklinikum Freiburg1,180
Completed
Not Applicable
A study of the long-term and short-term efects of Snoezelen and Reminiscence therapy on patients suffering from dementia who have associated agitated behavior problemsISRCTN60367715Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)20
Active, not recruiting
Not Applicable
?The effect of acute and chronic administration of the CCK1 receptor antagonist Dexloxiglumide (CR2017) on 24-h pH metry, LES motor and symptoms? pattern, in patients with gastroesophageal reflux disease (GERD). A randomized, double-blind, placebo controlled study? - NDgastroesaphageal reflux disease (GERD)MedDRA version: 9.1Level: LLTClassification code 10017885Term: Gastrooesophageal reflux diseaseEUCTR2007-003478-25-ITROTTAPHARM / ROTTA RESEARCH LABORATORIUM
Recruiting
Not Applicable
The effects of yoga and music on beta-endorphin, serotonin, body composition, anxiety and depression in obese obese womeIRCT20220304054178N1The University of Kordestan30